• Tidak ada hasil yang ditemukan

DESRIYAN PURNAMA PUTRA G2A009076 BAB VIII KTI

N/A
N/A
Protected

Academic year: 2017

Membagikan "DESRIYAN PURNAMA PUTRA G2A009076 BAB VIII KTI"

Copied!
12
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

1. Dan L Longo, Dennis L Kasper, J Larry Jameson, Anthony S Fauci, Stephen L Hauser, Joseph Loscalzo. Harrison’s Principles of internal medicine. USA:

The McGraw-Hill Companies; 2012.

2. Undurti N Das. Insulin in Sepsis and Septic Shock. JAPI. 2003; 51:695-700. 3. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F,

Schietz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouikkon R. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001; 345: 1359-67. 4. Jonathan Cohen. The immunopathogenesis of sepsis. Nature [Internet]. 2002

[cited 2012 October 8]; 420:885-91. Available from: www.nature.com/nature. 5. F Wong, M Bernardi, R Balk, B Christman, R Moreau, G Garcia-Tsao, et al.

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut [Internet].2005 [cited 2012 December 24]; 54:718-725. Available from: gut.bml.com.

6. Arthur C Guyton, John E Hall. Buku ajar fisiologi kedokteran. Jakarta: EGC; 2007.

7. Anselm O Agwunobi, Claire Reid, Paula Maycock, Roderick A Little, Gordon L Carlson. Insulin Resistence and Substrate Utilization in Human Endotoxemia. JCE & M. 2000; 85: 3770-3778.

(2)

9. Paul E Marik, Murugen Raghavan. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004; 30: 748-56.

10.Alain Cariou, Christophe Vinsonneau, Jean-Francois Dhainaut. Adjunctive therapies in sepsis: An evidence-based review. Crit Care Med. 2004;32(11):S562-S570.

11.Eric A J Hoste, Norbert H Lameire, Raymond C Vanholder, Dominique D Benoit, Johan M A Decruyenaere, Francis A Colardyn. Acete Renal Failure in Patients with Sepsis in a Surgical ICU: Predictive Factor, Incidence, Comorbidity, and Outcome. J Am Soc Nephrol.2003; 14:1022-30.

12.Greg S Martin, Stephanie Eaton, Meredith Mealer, Marc Moss. Extravascular lung water in patients with severe sepsis: a prospective cohort study. Critical Care [Internet]. 2005 [cited 2012 December 24]; 9(2): R74-R82. Available from: http://ccforum.com/content/9/2/R74

13.Andreas Hillenbrand, Manfred Weiss, Uwe Knippschild, Anna Maria Wolf, Markus Huber-Lang. Sepsis-induced adipokine change with regard to insulin resistance. International Journal of Inflamation. 2012:1-7.

14.Can Ince. The microcirculation is the motor of sepsis. Critical Care [Internet]. 2005 [cited 2012 December 24]; 9(suppl 4): S13-S19. Available from: http://ccforum.com/supplements/9/S4/S13.

15.Soren Kaeseler Andersen, Jakob Gjedsted, Christian Christiansen, Else Tonnesen. The roles of insulin and hyperglycemia in sepsis pathogenesis. Journal of Leukocyte Biology. 2004; 75: 413-21.

(3)

therapy for critically ill trauma patients admitted to ICU. M E J Anesth [Internet]. 2010 [cited 2013 January 24]; 20(5): 659-66. Available from: http://www.meja.aub.edu.lb/20_5.html

17.Abbas E Kitabchi, Guillermo E Umpierrez, Mary Beth Murphy, Eugene J Barrett, Robert A Kreisberg, Johan I Malone, et al. Management of hyperglycaemic crises in patients with diabetes. Diabetes Care. 2001; 24: 131-53.

18.John Koskinas, Ilias P Gomatos, Dina G Tiniakos, Nikolas Memos, Maria Boutsikou, Aspasia Garatzioti, Athanasios Archimandritis, et al. Liver histology in ICU patients dying from sepsis: A clinic-pathological study. World J Gastroenterol. 2008 [Internet]. 2008 [cited 2013 January 22]; 14(9):1389-93. Available from: www.wjgnwt.com

19.Herbert Spapen. Liver perfusion in sepsis, septic shock, and multiorgan failure. The Anatomical Record [Internet]. 2008 [cited 2013 January 22]; 291:714-20. Available from: Wiley Interscience.

20.Robert KM, Daryl KG, Victor WR. Biokimia harper. Jakarta: EGC; 2009. 21.Sacha Zeerleder, Erik Hack, Walter A Wuillemin. Disseminated Intravascular

Coagulation in Sepsis. CHEST [Internet]. 2005 [cited 2013 January 3]; 128:2864-75. Available from: http://journal.publications.chestnet.org/

22.Frank M Brunkhorst, Christoph Engel, Frank Bloos, et al. Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. N Engl J Med. 2008; 358: 125-39.

(4)

24.Ricardo Gracia Branco, Robert Charles Tasker, Pedro Celiny Ramos Gracia, et al. Glycemic control and insulin therapy in sepsis and critical illness. Jurnal de Pediatria. 2007; 83(Suppl 5): S128-S136.

25.Zdenek Rusavy, Vladimir Sramek, Silvie Lacigova, et al. Influence of insulin on glucose metabolisme and energy expenditure in septic patients. Critical Care. 2004; 8: R213-R220.

(5)

Lampiran

Descriptive Statistics

N Minimum Maximum Mean Std. Deviation

Jenis Kelamin Pasien 22 1 2 1.41 .503

Usia Pasien 22 34 79 55.64 12.894

GDS Sebelum Pemberian

Insulin

22 100 585 279.41 130.912

GDS Sesudah Pemberian

Insulin

22 62 401 205.91 85.383

Valid N (listwise) 22

Case Processing Summary

Cases

Valid Missing Total

N Percent N Percent N Percent

GDS Sebelum Pemberian

Insulin

22 100.0% 0 .0% 22 100.0%

GDS Sesudah Pemberian

Insulin

(6)

Jenis Kelamin Pasien

Frequency Percent Valid Percent

Cumulative

Statistic Std. Error

GDS Sebelum Pemberian

Insulin

Mean 279.41 27.910

95% Confidence Interval for

Mean

Lower Bound 221.37

Upper Bound 337.45

5% Trimmed Mean 272.76

Median 280.00

Variance 17137.872

Std. Deviation 130.912

Minimum 100

Maximum 585

Range 485

Interquartile Range 215

Skewness .671 .491

(7)

Tests of Normality

a. Lilliefors Significance Correction

*. This is a lower bound of the true significance. GDS Sesudah Pemberian

Insulin

Mean 205.91 18.204

95% Confidence Interval for

Mean

Lower Bound 168.05

Upper Bound 243.77

5% Trimmed Mean 203.00

Median 199.00

Variance 7290.277

Std. Deviation 85.383

Minimum 62

Maximum 401

Range 339

Interquartile Range 107

Skewness .638 .491

(8)
(9)

Paired Samples Statistics

Mean N Std. Deviation Std. Error Mean

Pair 1 GDS Sebelum Pemberian

Insulin

279.41 22 130.912 27.910

GDS Sesudah Pemberian

Insulin

(10)

Paired Samples Correlations

N Correlation Sig.

Pair 1 GDS Sebelum Pemberian

Insulin & GDS Sesudah

(11)

IDENTITAS

Nama : Desriyan Purnama Putra

NIM : G2A009076

Tempat/Tanggal Lahir : Rimbo Bujang/ 23 Desember 1991 Jenis Kelamin : Laki-laki

Alamat : Jalan Bukit Kelapa Sawit VII AD 27 Tembalang

No Telepon : -

No HP : 085266923213

Email : [email protected]

Riwayat Pendidikan Formal

1. SD : SD 81/VIII Lulus Tahun: 2003 2. SMP : SMP N 3 Tebo Lulus Tahun: 2006 3. SMA : SMA N 2 Tebo Lulus Tahun: 2009 4. FK Undip : Masuk Tahun: 2009

Keanggotaan Organisasi

Anggota Maladica ( Mahasiswa Pecianta Alam Medica) FK Undip sejak 2010

Pengalaman Penelitian

(12)

Referensi

Dokumen terkait

Urgency: Therefore research needed in the pharmaceutical services in the form of monitoring the treatment of patients with type 2 diabetes mellitus receiving insulin therapy to

Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.. Insulin Resistance and Type

Insulin merupakan obat utama untuk diabetes mellitus tipe 1 dan beberapa jenis diabetes mellitus tipe 2 yang tidak dapat diatasi hanya dengan diet.. dan antidiabetik oral.

Initiation of insulin therapy in patients with type 2 diabetes could be conducted in patients who fail oral antidiabetic therapy OAD, has poor blood glucose control A1C> 7.5% or

The results of various studies on the comparison of insulin pens in type 1 diabetes insulin- dependent, type 2 non-insulin-dependent diabetes, and gestational diabetes have shown that

Introduction Type 2 diabetes mellitus T2DM is an insulin-insufficient disease characterised pathophysiologically by beta cell dysfunction and insulin resistance.1 Glycaemic control is

"DEMONSTRATION OF PRECISE RELATIONSHIPS AND LINKS BETWEEN TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND PARKINSON’S DISEASE", International Journal of Research -GRANTHAALAYAH, 2020

"Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine", Therapeutic Advances in Endocrinology and Metabolism, 2017 Publicat ion